MedTrace Logo

SPECT/CT in Measuring Lung Function in Patients With Cancer Undergoing Radiation Therapy

NCT01982123 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2018-12-13

Study results available
· View outcomes & findings →

Summary

This pilot clinical trial studies single photon emission computed tomography (SPECT)/computed tomography (CT) in measuring lung function in patients with cancer undergoing radiation therapy. Diagnostic procedures that measure lung function may help doctors find healthy lung tissue and allow them to plan better treatment.

Conditions

  • Lung Carcinoma
  • Malignant Neoplasm

Interventions

DIAGNOSTIC_TEST

SPECT/CT

Undergo 99mTc-MAA and 99mTc-DTPA SPECT/CT mid-radiation and post-radiation

PROCEDURE

Single Photon Emission Computed Tomography

Undergo 99mTc-MAA and 99mTc-DTPA SPECT/CT

RADIATION

Technetium Tc-99m Albumin Aggregated

Undergo 99mTc-MAA SPECT/CT

DRUG

Technetium Tc-99m DTPA

Undergo 99mTc-DTPA SPECT/CT

Sponsors & Collaborators

Principal Investigators

  • Jing Zeng · Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-17
Primary Completion
2017-09-13
Completion
2017-09-13

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01982123 on ClinicalTrials.gov